NewsRelease
BiotechSupport Group presented 2 posters at the ASMS 2020 Virtual Conferenceon Mass Spectrometry & Allied Topics
MONMOUTHJUNCTION, NJ,June12, 2020 -- Biotech Support Group presented two posters at the ASMS2020 Reboot, which became a virtual conference due to the pandemic.The posters were:
MattKuruc1;Swapan Roy1;Wilma Mesker2;Rob Tollenaar2;1BiotechSupport Group LLC, Monmouth Junction, NJ; 2LeidenUniversity Medical Center, Leiden, Netherlands
Briefdescription: Commercial enthusiasm continues for the prospects ofmeasuring cancer non-invasively through liquid biopsy biomarkers.However, current biomarkers only serve to report tumor burden, whichis not the full picture of progressive disease. The other largelyneglected part of tumors, comes from the cooperation of the normalhost response to acquired inflammation at the primary site. Thisstromal conditioning assists the tumor ecosystem and affectsresistance to treatment and final outcomes. The innate immune systemcooperates in this response, and we now report proteomic methods tomonitor that influence from blood. With these methods, we aim tocharacterize and quantify Stroma Liquid Biopsy™ biomarkers inpatient sera, to correlate to Tumor-Stroma Ratio scoring methodsdeveloped at Leiden University Medical Center (LUMC).
MattKuruc1;Swapan Roy1;Johan Jakobsson2;Raik Wagner2;Christer Malm2;1BiotechSupport Group (BSG) LLC, Monmouth Junction, NJ; 2ProTest Diagnostics AB (PTD), Umeå, Sweden
Briefdescription: Dried blood spots (DBS) provide a cost effectivetransport and archival method for monitoring of changes in the redblood cell (RBC) proteome due to disease or ex vivo storage, such ascryopreservation used for autologous blood doping (ABD). PTD hasdeveloped proprietary peptides for detection of ABD. We assessed thedetectability of selected peptides with DBS as archival method.
“Thesetwo posters highlight the value of collaborative partners jointlyworking to commercialize new biomarkers using novel proteomic sampleprep products and methods. It is very exciting to share thesedevelopments with a dedicated group at the forefront of massspectrometry research”, states Dr. Swapan Roy, Ph.D., President andFounder of Biotech Support Group.
Formore information on the BSG complete line ofAlbumin& IgG Removal products,visit: https://www.biotechsupportgroup.com/Albumin-Removal-s/307.htm
Formore information on the BSG complete line of HemoglobinRemovalproducts, visit:
https://www.biotechsupportgroup.com/Hemoglobin-Removal-s/312.htm
AboutBiotech Support Group LLC
Convergingwith cultural and technological disruptions forthcoming inhealthcare, Biotech Support Group develops methods for cost effectiveand efficient sample prep essential for these expanding markets.Following a tiered business strategy, the company continues itsgrowth in the consumable research products area supporting therapidly expanding installation of LC-MS instrument and computationalinfrastructure. For this market, key products include: AlbuVoid™and AlbuSorb™ for albumin depletion, Cleanascite™ for lipidadsorption, and HemogloBind™ and HemoVoid™ for hemoglobinremoval. From these innovations, the company has acquiredknowledgebase and biomarker intellectual property assets that supportdiscoveries of protein markers from blood, with special emphasis onearly detection and personalized medical decisions for cancerpatients. For more information, go tohttps://www.biotechsupportgroup.com
Contact:MatthewKuruc 732-274-2866 [email protected]